1.
Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed
by Di Cresce, C
The Journal of pharmacology and experimental therapeutics, September 2011, Vol.338(3), pp.952-63

2.
The Effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model.
by Hanly, L
Anticancer research, September 2012, Vol.32(9), pp.3791-3798

3.
Metallothionein protein and mRNA in the toxic milk mouse
by Koropatnick, J
The Biochemical journal, 15 November 1994, Vol.304(Pt 1), pp.318-9

4.
A mutant mouse ( tx ) with increased hepatic metallothionein stability and accumulation
by Koropatnick, J
Biochemical Journal, 12/01/1993, Vol.296(2), pp.443-449

5.
Temporal changes in metallothionein gene transcription in rat kidney and liver: relationship to content of mercury and metallothionein protein.
by Zalups, R K
The Journal of pharmacology and experimental therapeutics, October 2000, Vol.295(1), pp.74-82

6.
Mouse hepatic metallothionein-I gene cleavage by micrococcal nuclease is enhanced after induction by cadmium
by Koropatnick, J
Nucleic acids research, 25 May 1983, Vol.11(10), pp.3255-67

7.
Acute treatment of mice with cadmium salts results in amplification of the metallothionein-1 gene in liver
by Koropatnick, J
Nucleic acids research, 12 August 1985, Vol.13(15), pp.5423-39

8.
Rodent PSP94 gene expression is more specific to the dorsolateral prostate and less sensitive to androgen ablation than probasin.
by Imasato, Y
Endocrinology, May 2001, Vol.142(5), pp.2138-2146

9.
Effect of non‐toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide‐induced activation
by Koropatnick, J
British Journal of Pharmacology, February 1997, Vol.120(5), pp.797-806

10.
The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population.
by Nichols, A C
Current oncology (Toronto, Ont.), August 2013, Vol.20(4), pp.212-219

11.
Antisense‐induced down‐regulation of thymidylate synthase and enhanced cytotoxicity of 5‐FUdR in 5‐FUdR‐resistant HeLa cells
by Ferguson, Peter J
British Journal of Pharmacology, December 2001, Vol.134(7), pp.1437-1446

12.
Zinc-metallothionein levels are correlated with enhanced glucocorticoid responsiveness in mouse cells exposed to ZnCl(2), HgCl(2), and heat shock
by Demoor, J M
Toxicological sciences : an official journal of the Society of Toxicology, November 2001, Vol.64(1), pp.67-76

13.
Enhanced transcription of metallothionein genes in rat kidney: effect of uninephrectomy and compensatory renal growth.
by Zalups, R K
The American journal of physiology, April 1995, Vol.268(4 Pt 2), pp.F643-F650

14.
Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
by M Y Gabril
Gene Therapy, 2002, Vol.9(23), p.1589

15.
Use of cultured human cells in short-term tests for chemical carcinogens.
by Stich, H F
Environmental Health Perspectives, 02/1978, Vol.22, pp.131-132

16.
Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering
by Xiang, J
Immunology, April 1993, Vol.78(4), pp.574-81

17.
Antisense down-regulation of metallothionein in a human monocytic cell line alters adherence, invasion, and the respiratory burst.
by Leibbrandt, M E
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, January 1994, Vol.5(1), pp.17-25

18.
Antisense down‐regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5‐FUdR, 5‐FU and Tomudex in HeLa cells
by Ferguson, Peter J
British Journal of Pharmacology, August 1999, Vol.127(8), pp.1777-1786

19.
Infertility: a non-event transition
by Koropatnick, S
Fertility and sterility, January 1993, Vol.59(1), pp.163-71
